C21 Reports Q2 Revenue Up 14% QoQ, South Reno Cannabis Dispensary Sees 53% Sales Growth
C21 Reports Q2 Revenue Up 14% QoQ, South Reno Cannabis Dispensary Sees 53% Sales Growth
The company said there is no equivalent time period to the second quarter report in the company's historical results due to the previously reported change in fiscal year end from Jan. 31 to March 31.Vertically integrated cannabis company C21 Investments Inc. (CSE:CXXI) (OTCQX:CXXIF) announced its interim unaudited financial statements and management discussion and analysis on Thursday for its second quarter ending Sept. 30, 2024.
垂直一體化的大麻股公司C21 Investments Inc.（cse:CXXI）（OTCQX:CXXIF）宣佈其截至2024年9月30日第二季度的中期未經審計的財務報表和管理層討論與分析報告於週四發佈。
"We are pleased with the strong performance and positive customer reception of our new dispensary during its first quarter of operations," said Sonny Newman, CEO and president. "These results have exceeded our expectations and we continue to see robust sales growth into the new quarter."
「我們對我們新藥房首個營業季度的強勁表現和積極客戶反饋感到滿意，」首席執行官兼總裁Sonny Newman表示。「這些成績超出了我們的預期，我們預計新季度銷售額會繼續保持強勁增長。」
Read Also: Cannabis Co. C21 Investments Reports Stub Period Revenue Of $4.5M Following $3.5M Deep Roots Harvest Acquisition
閱讀也可了解：Cannabis Co. C21 Investments報告 Stub 期營收爲450萬元，收購深根收穫350萬美元。
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
- 訂閱本新聞快訊，每天免費獲取Benzinga獨家分析和大麻股行業及市場的最新資訊。如果您對業務認真，不容錯過。在這裏訂閱我們的新聞簡報。
Q2 Financial Highlights
2024年第二季度財務亮點
The company said there is no equivalent time period to the second quarter report in the company's historical results due to the previously reported change in fiscal year end from Jan. 31 to March 31.
公司表示，由於先前報告的財政年度結束日期從1月31日變更爲3月31日，公司歷史結果中沒有與第二季度報告相當的時間段。
- Revenue totaled $7.5 million, representing a 14% increase from the first quarter.
- Gross margin rose to 43.5%, up from 31% in the prior quarter, fueled by operational efficiencies and higher retail revenues.
- The South Reno dispensary ramped up sales by 53% within the quarter, reaching $416,000 in Sept. and continued to perform well post-quarter. The dispensary sales increased by 14% in Oct. reaching $475,000.
- Adjusted EBITDA came in positive at $1.3 million, up from $0.3 million in the previous period, reflecting better margins and retail growth.
- Free cash flow turned positive, reaching $0.8 million, compared to a negative $0.09 million in the first quarter.
- Net loss decreased to $845,132.
- Selling, general and administrative expenses increased by 3% increase due to the new dispensary's lease and labor costs.
- Total assets grew to $58.6 million, while liabilities increased to $28.3 million. The South Reno dispensary sales increased by 14% in October, reaching $475,000.
- 營業收入總額爲750萬美元，較第一季度增長14%。
- 毛利率提高到43.5%，高於上一季度的31%，這得益於運營效率和更高的零售收入。
- 南里諾大麻股藥房在本季度銷售額增加了53%，達到416,000美元，9月份繼續表現良好，季末後繼續表現出色。藥房銷售額在10月份增長了14%，達到475,000美元。
- 調整後的EBITDA爲正值130萬美元，較上一期的30萬美元有所增長，反映出更好的利潤率和零售增長。
- 自由現金流轉正，達到80萬美元，相比第一季度的負9萬美元有所增長。
- 淨損失降至845,132美元。
- 由於新藥房的租賃和勞動成本，銷售、一般和行政費用增加了3%。
- 總資產增長至5860萬美元，而負債增加至2830萬美元。南里諾大麻股在十月份的總銷售額增長了14%，達到475,000美元。
- The Biggest Little Company In Cannabis: C21 Investments Dominates Reno, NV
- 大麻行業的最大公司：C21 Investments主導內華達州里諾
譯文內容由第三人軟體翻譯。
